Home > Drug Search >
  • company_query: Ardelyx
  •   > 
Drug Filter
Category:
chemistry (31) biology (1)
Status:
Approved (1) Phase Ⅲ (7) Phase Ⅱ (10) Phase Ⅰ (13) IND Filing (1)
Clinical Stage:
Pending (4) Active (21) Discontinued (5)
Indication:
Acute myeloid Leukemia (AML) (1) Advanced breast cancer (1) Anemia (1) Appendicitis (1) Breast cancer (1) Hyperkalaemia (1) Chronic lymphocytic leukemia (CLL) (2) Chronic myeloid leukemia (CML ) (1) Common warts (1) Gastric cancer (3) Gastrointestinal stromal tumors (GISTs) (1) Growth hormone deficit (1) HBV infection (2) HIV infection (2) Huntington's disease (1) Hypertension (1) Irritable bowel syndrome with constipation (IBS-C) (1) Lung cancer (3) Metastatic melanoma (1) Myelodysplastic syndrome (MDS) (1) Niemann-Pick diseases (1) Non small cell lung cancer (NSCLC) (3) Non-alcoholic fatty liver disease (NAFLD) (1) Non-Hodgkin’s lymphoma (NHL) (1) Ovarian cancer (1) Pancreatic cancer (1) Pelvic inflammatory disease (1) Peptic ulcer (2) Primary hypogonadism (1) Dermal scarring (1) Sensitive anaerobic bacteria infections (1) Solid tumours (3) Type 2 diabetes (3) Systemic bacterial infections (1) Urothelial cancer (1) B-cell lymphoma (1) Renal carcinoma (1) Hyperphosphatemia (1) Growth failure (1) Gastrointestinal motility disorders (1) Androgenic alopecia (1) Gallstone (1) Esophagus cancer (1) Lipodystrophy (1) Liver cancer (2)
Aprv. Year:
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top